Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unrelated Umbilical Cord Blood Transplantation in High Risk Hematologic Malignancies
NCT00003335Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jan 1998
- Primary completion
- Nov 2007
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), myelodysplastic syndrome (MDS), non-Hodgkin lymphoma (NHL), sponsored by Case Comprehensive Cancer Center. Started Jan 1998; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)myelodysplastic syndrome (MDS)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003335.